Colorectal cancer in inflammatory bowel disease
β Scribed by Rupert W L Leong; Jenn H Koo
- Book ID
- 108952231
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 69 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0815-9319
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Ulcerative colitis and Crohn's disease both confer an increased risk of developing colorectal cancer. The use of 5-aminosalicylate as a remission-inducing agent has been long accepted. Its use as a potential chemoprophylactic agent has been proposed and is used by some practitioners. This review exa
## Background: The histological variability in colitis-associated colorectal cancer (crc in inflammatory bowel disease [ibd]) and the association to clinical factors is unknown. ## Methods: In population-based material including 67 patients with crc in ibd, histopathology of the cancers and tissu